Antibody Drug Conjugates Market Size, Share, Revenue, Trends And Drivers For 2024-2033

LANDON, GREATER LANDON, UK, April 1, 2024 /EINPresswire.com/ -- The global market reports from The Business Research Company have been updated with the most recent market sizing data for 2024 and projections extended to 2033

The Business Research Company’s “Antibody Drug Conjugates Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the antibody drug conjugates market size is predicted to reach $24.8 billion in 2028 at a compound annual growth rate (CAGR) of 23.4%.

The growth in the antibody drug conjugates market is due to the increasing number of clinical trial studies. North America region is expected to hold the largest antibody drug conjugates market share. Major players in the antibody drug conjugates market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited.

Antibody Drug Conjugates Market Segments
1. By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Other Types
2. By Product: Adcertis, Kadcyla, Other Products
3. By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology
4. By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications
4. By End User: Hospital, Clinics, Other End Users
5. By Geography: The global antibody drug conjugates market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=2569&type=smp

Antibody-drug conjugates (ADCs) refer to medications that are specifically designed to administer chemotherapy to cancer cells. ADCs deliver chemotherapy via a linker connected to a monoclonal antibody that binds to a specific target expressed on cancer cells. As soon as the ADC binds to its target (a cancer protein or receptor), a cytotoxic chemical is released into the cancer cell.

Read More On The Antibody Drug Conjugates Global Market Report At:
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antibody Drug Conjugates Market Characteristics
3. Antibody Drug Conjugates Market Trends And Strategies
4. Antibody Drug Conjugates Market – Macro Economic Scenario
5. Antibody Drug Conjugates Market Size And Growth
……
27. Antibody Drug Conjugates Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Antibody Drug Conjugates Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Convalescent Plasma Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Oncology Biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn